The U.S. Food and Drug Administration (FDA) is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON. These products are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, but they are in fact illegal drugs that contain potentially harmful undeclared ingredients. These products have not been approved by FDA, and there is no guarantee of their safety and...
Read moreVoluntary recalls were issued for specific lots of two opioid pain relievers and one medication for tension headaches. The affected drugs... Read more »
Full Question: A month ago I was diagnosed with ophthalmology migraine. I am taking 25mg of Topamax twice a day and Butalb acetamin- caff... Read more »
Full Question: I have what was called "silent" migraines with numbness in face, vision problems, auras, sometimes stomach is upset, and... Read more »
If you take a butalbital medication for your Migraines or another pain issue, you need to be aware of a recall by Qualitest... Read more »
BP-3 or Benzophenone-3 is a sunscreen ingredient that you will typically find in sun protection products, skin care lotions, lipsticks,... Read more »
The ingredient that puts the "pep" in hot peppers may also cause weight loss, South Korean researchers say. Capsaicin appears to trigger proteins... Read more »
This study will compare Trexima to to a butalbital-containing combination medication, acetaminophen, caffeine, and the butalbital med Fioricet in... Read more »
Results from a new study suggest that some parts of the Mediterranean diet are more beneficial to good health than others. In a new study at the... Read more »
Every year, new skin-care treatments come out promising amazing results, and while some of these deliver on their promises, others do not. Reporters... Read more »
Many people take red yeast rice supplements because of claims that the products can improve cholesterol levels. But new research published in the... Read more »